Tanini Annita's Form 4 filing
Keros Therapeutics, Inc. (KROS) · filed Aug 20, 2026
- Accession no.
- 0002146784-26-000004
- Filed
- Aug 20, 2026, 4:10 PM ET
- Trade date
- Aug 18, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $12.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tanini AnnitaCIK 0002146784 | Officer (Corp. Controller & VP, Finance) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | Common Stock | SSaleDisposed | −1,224 | $10.29 | −$12,594.96 | 45,144 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.